• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Molecular Engineering of Ghfp, the Gonococcal Orthologue of Neisseria meningitidis Factor H Binding Protein.淋病奈瑟菌同源物Ghfp(淋病奈瑟菌因子H结合蛋白)的分子工程
Clin Vaccine Immunol. 2015 Jul;22(7):769-77. doi: 10.1128/CVI.00794-14. Epub 2015 May 6.
2
Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein.淋球菌脑膜炎奈瑟菌因子 H 结合蛋白同源物的独特结合和免疫原性。
PLoS Pathog. 2013;9(8):e1003528. doi: 10.1371/journal.ppat.1003528. Epub 2013 Aug 1.
3
Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.脑膜炎球菌重组嵌合因子H结合蛋白疫苗诱导的杀菌抗体反应。
Infect Immun. 2008 Jun;76(6):2568-75. doi: 10.1128/IAI.00033-08. Epub 2008 Mar 24.
4
Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1.因子 H 结合蛋白变异体 1.1 诱导的杀菌活性血清中序列变异的影响。
Vaccine. 2011 Jan 29;29(5):1072-81. doi: 10.1016/j.vaccine.2010.11.064. Epub 2010 Dec 3.
5
Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.用重组截短脑膜炎奈瑟菌-巨噬细胞感染增强蛋白(rT-Nm-MIP)免疫可诱导产生对淋病奈瑟菌具有交叉反应性和杀菌活性的鼠抗体。
Vaccine. 2018 Jun 22;36(27):3926-3936. doi: 10.1016/j.vaccine.2018.05.069. Epub 2018 May 24.
6
A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups.脑膜炎球菌因子H结合蛋白N端结构域中一个能引发跨抗原变异组杀菌抗体的区域。
Mol Immunol. 2009 May;46(8-9):1647-53. doi: 10.1016/j.molimm.2009.02.021. Epub 2009 Mar 14.
7
Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates.非功能性变异 3 因子 H 结合蛋白作为脑膜炎球菌疫苗候选物。
Infect Immun. 2014 Mar;82(3):1157-63. doi: 10.1128/IAI.01183-13. Epub 2013 Dec 30.
8
Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.脑膜炎奈瑟菌的因子H短共识重复序列6(SCR 6)与因子H结合蛋白的结合,以及因子H的SCR 18至20与淋病奈瑟菌孔蛋白的结合的功能比较。
Infect Immun. 2009 May;77(5):2094-103. doi: 10.1128/IAI.01561-08. Epub 2009 Mar 9.
9
Gonococcal MtrE and its surface-expressed Loop 2 are immunogenic and elicit bactericidal antibodies.淋球菌 MtrE 及其表面表达的环 2 具有免疫原性,可诱导杀菌抗体。
J Infect. 2018 Sep;77(3):191-204. doi: 10.1016/j.jinf.2018.06.001. Epub 2018 Jun 12.
10
Identification of epitopes recognized by monoclonal antibodies SM1 and SM2 which react with all pili of Neisseria gonorrhoeae but which differentiate between two structural classes of pili expressed by Neisseria meningitidis and the distribution of their encoding sequences in the genomes of Neisseria spp.鉴定单克隆抗体SM1和SM2所识别的表位,这两种抗体可与淋病奈瑟菌的所有菌毛发生反应,但能区分脑膜炎奈瑟菌表达的两种菌毛结构类型,以及它们的编码序列在奈瑟菌属基因组中的分布情况。
J Gen Microbiol. 1989 Dec;135(12):3239-51. doi: 10.1099/00221287-135-12-3239.

引用本文的文献

1
Structural characterization of a cross-protective natural chimera of factor H binding protein from meningococcal serogroup B strain NL096.来自B群脑膜炎球菌菌株NL096的补体H因子结合蛋白交叉保护性天然嵌合体的结构表征
Comput Struct Biotechnol J. 2022 Apr 18;20:2070-2081. doi: 10.1016/j.csbj.2022.04.011. eCollection 2022.
2
Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens.结构与计算生物学在免疫原性疫苗抗原设计中的应用。
J Immunol Res. 2015;2015:156241. doi: 10.1155/2015/156241. Epub 2015 Oct 7.
3
The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement.恶性疟原虫血液阶段获取补体H因子家族蛋白以逃避人类补体的破坏。
Cell Microbiol. 2016 Apr;18(4):573-90. doi: 10.1111/cmi.12535. Epub 2015 Nov 12.

本文引用的文献

1
Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention.使用多组分重组B群脑膜炎球菌疫苗(4CMenB)预防细菌性脑膜炎。
Immunotherapy. 2014;6(4):395-408. doi: 10.2217/imt.14.11.
2
Two cross-reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties.两种交叉反应性单克隆抗体识别脑膜炎奈瑟菌因子 H 结合蛋白上的重叠表位,但具有不同的功能特性。
FASEB J. 2014 Apr;28(4):1644-53. doi: 10.1096/fj.13-239012. Epub 2013 Dec 26.
3
Global epidemiology of invasive meningococcal disease.侵袭性脑膜炎球菌病的全球流行病学。
Popul Health Metr. 2013 Sep 10;11(1):17. doi: 10.1186/1478-7954-11-17.
4
Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein.淋球菌脑膜炎奈瑟菌因子 H 结合蛋白同源物的独特结合和免疫原性。
PLoS Pathog. 2013;9(8):e1003528. doi: 10.1371/journal.ppat.1003528. Epub 2013 Aug 1.
5
An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands.分析 50 年来荷兰脑膜炎奈瑟菌 fHbp、NadA 和 NHBA 的序列变异性。
PLoS One. 2013 May 24;8(5):e65043. doi: 10.1371/journal.pone.0065043. Print 2013.
6
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.预测脑膜炎球菌多组份疫苗(4CMenB)在欧洲的菌株覆盖率:定性和定量评估。
Lancet Infect Dis. 2013 May;13(5):416-25. doi: 10.1016/S1473-3099(13)70006-9. Epub 2013 Feb 13.
7
Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen.定义因子 H 结合蛋白上的保护性表位,因子 H 结合蛋白是脑膜炎球菌关键毒力因子和疫苗抗原。
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3304-9. doi: 10.1073/pnas.1222845110. Epub 2013 Feb 8.
8
Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules.基于结构的宿主和病原体分子修饰的脑膜炎球菌疫苗的设计和评估。
PLoS Pathog. 2012;8(10):e1002981. doi: 10.1371/journal.ppat.1002981. Epub 2012 Oct 25.
9
The factor H binding protein of Neisseria meningitidis interacts with xenosiderophores in vitro.脑膜炎奈瑟菌因子 H 结合蛋白在体外与外源性铁载体相互作用。
Biochemistry. 2012 Nov 20;51(46):9384-93. doi: 10.1021/bi301161w. Epub 2012 Nov 12.
10
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents.一项脑膜炎奈瑟菌 B 群二价 rLP2086 疫苗在健康儿童和青少年中进行的随机、对照、1/2 期临床试验。
Pediatr Infect Dis J. 2013 Apr;32(4):364-71. doi: 10.1097/INF.0b013e31827b0d24.

淋病奈瑟菌同源物Ghfp(淋病奈瑟菌因子H结合蛋白)的分子工程

Molecular Engineering of Ghfp, the Gonococcal Orthologue of Neisseria meningitidis Factor H Binding Protein.

作者信息

Rippa Valentina, Santini Laura, Lo Surdo Paola, Cantini Francesca, Veggi Daniele, Gentile Maria Antonietta, Grassi Eva, Iannello Giulia, Brunelli Brunella, Ferlicca Francesca, Palmieri Emiliano, Pallaoro Michele, Aricò Beatrice, Banci Lucia, Pizza Mariagrazia, Scarselli Maria

机构信息

Novartis Vaccines Srl, a GSK Company, Siena, Italy.

Centro Risonanze Magnetiche (CERM) and Department of Chemistry, University of Florence, Sesto Fiorentino, Italy.

出版信息

Clin Vaccine Immunol. 2015 Jul;22(7):769-77. doi: 10.1128/CVI.00794-14. Epub 2015 May 6.

DOI:10.1128/CVI.00794-14
PMID:25947148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4478525/
Abstract

Knowledge of the sequences and structures of proteins produced by microbial pathogens is continuously increasing. Besides offering the possibility of unraveling the mechanisms of pathogenesis at the molecular level, structural information provides new tools for vaccine development, such as the opportunity to improve viral and bacterial vaccine candidates by rational design. Structure-based rational design of antigens can optimize the epitope repertoire in terms of accessibility, stability, and variability. In the present study, we used epitope mapping information on the well-characterized antigen of Neisseria meningitidis factor H binding protein (fHbp) to engineer its gonococcal homologue, Ghfp. Meningococcal fHbp is typically classified in three distinct antigenic variants. We introduced epitopes of fHbp variant 1 onto the surface of Ghfp, which is naturally able to protect against meningococcal strains expressing fHbp of variants 2 and 3. Heterologous epitopes were successfully transplanted, as engineered Ghfp induced functional antibodies against all three fHbp variants. These results confirm that structural vaccinology represents a successful strategy for modulating immune responses, and it is a powerful tool for investigating the extension and localization of immunodominant epitopes.

摘要

对微生物病原体产生的蛋白质序列和结构的了解正在不断增加。除了提供在分子水平上揭示发病机制的可能性外,结构信息还为疫苗开发提供了新工具,例如有机会通过合理设计改进病毒和细菌疫苗候选物。基于结构的抗原合理设计可以在可及性、稳定性和变异性方面优化表位库。在本研究中,我们利用关于脑膜炎奈瑟菌因子H结合蛋白(fHbp)特征明确的抗原的表位图谱信息,对其淋球菌同源物Ghfp进行工程改造。脑膜炎球菌fHbp通常分为三种不同的抗原变体。我们将fHbp变体1的表位引入到Ghfp表面,Ghfp天然能够抵御表达变体2和3的fHbp的脑膜炎球菌菌株。由于工程改造的Ghfp诱导出针对所有三种fHbp变体的功能性抗体,异源表位成功移植。这些结果证实,结构疫苗学是调节免疫反应的成功策略,也是研究免疫显性表位的范围和定位的有力工具。